Protalix BioTherapeutics
PLX
#7485
Rank
$87.66 M
Marketcap
$1.20
Share price
1.69%
Change (1 day)
-50.21%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2023 (TTM): $0.10000

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is $0.10. In 2022 the company made an earnings per share (EPS) of -$0.30 an increase over its 2021 EPS that were of -$0.62.

EPS history for Protalix BioTherapeutics from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.10000-133.33%
2022-$0.30-51.61%
2021-$0.62342.86%
2020-$0.14-88.71%
2019-$1.24-34.74%
2018-$1.90-70.92%
2017-$6.532153.35%
2016-$0.29-146.77%
2015$0.62-287.88%
2014-$0.3310%
2013-$0.30130.77%
2012-$0.13-56.67%
2011-$0.30-46.43%
2010-$0.5636.59%
2009-$0.4132.26%
2008-$0.31-93.4%
2007-$4.701298.53%
2006-$0.34-96.59%
2005-$9.8619.32%
2004-$8.261552.65%
2003-$0.50-0%
2002-$0.50-50%
2001-$1.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.86 1,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.96 1,860.00%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.64-740.00%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.00-2,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel